Equity Overview
Price & Market Data
Price: $1.55
Daily Change: +$0.0599 / 3.86%
Range: $1.43 - $1.55
Market Cap: $56,509,200
Volume: 808,223
Performance Metrics
1 Week: -11.76%
1 Month: -35.34%
3 Months: -65.03%
6 Months: -79.59%
1 Year: -81.68%
YTD: -81.57%
Company Details
Employees: 64
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.